Ocugen

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.51-$1.90
Market Cap
$559M
Shares Short
54M

Financials

See more
Revenue (12 Mos)
$4.7M
Revenue Growth (YoY)
20.3%
Gross Profit (12 Mos)
-$29.5M
Diluted EPS
-$0.19

News

See more

Yahoo Finance • 8 days ago

Ocugen to Present at Industry and Investor Conferences in October 2025

Yahoo Finance • 25 days ago

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

Yahoo Finance • last month

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

Yahoo Finance • 2 months ago

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

About

CEO
Dr. Shankar Musunuri M.B.A., Ph.D.
Address
11 Great Valley Parkway, Malvern, PA, United States, 19355
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
95